MetLife, Inc. is rated a buy due to its solid value, above-market dividend yield, and favorable technical chart despite ...

We recently published a list of 12 Best Health Insurance Stocks to Buy in 2025. In this article, we are going to take a look at where MetLife ... annual growth rate (CAGR) of 3.7% during 2025-2033 ...

MetLife offers a wide range of complex insurance products that exposes it to underwriting, investment, capital market, and interest-rate risks, making it difficult to predict overall risk exposure ...

In a report released today, Bob Huang from Morgan Stanley maintained a Buy rating on Metlife (MET – Research Report), with a price target of ...

We recently published a list of 12 Best Health Insurance Stocks to Buy in 2025. In this article, we are going to take a look at where MetLife ... Lower interest rates are expected to have ...

We recently published a list of 12 Best Health Insurance Stocks to Buy in 2025. In this article, we are going to take a look at where MetLife, Inc. (NYSE ... expected to grow at a compound annual ...

Keefe Bruyette lowered the firm’s price target on MetLife (MET) to $98 from $100 and keeps an Outperform rating on the shares.Maximize Your ...

MetLife Inc. closed 6.70% short of its 52-week high of $89.05, which the company reached on November 27th.